Health In Tech Announces Voluntary Extension of Lock-Up Period
Health In Tech (Nasdaq: HIT) announced on Dec 2, 2025 that its executive officers, vice presidents and board have voluntarily extended their existing lock-up by an additional six months beyond the original twelve-month restriction tied to the company's IPO.
Rhea-AI Summary
Health In Tech (Nasdaq: HIT) announced on Dec 2, 2025 that its executive officers, vice presidents and board have voluntarily extended their existing lock-up by an additional six months beyond the original twelve-month restriction tied to the company's IPO.
Under the extension, shares held by current executives and directors remain restricted from sale or transfer until June 20, 2026. Health In Tech completed its IPO on Dec 20, 2024, raising gross proceeds of $9.2 million, and says it continues investing in systems, distribution and service expansion.
Positive
- Lock-up extended by 6 months, signaling insider confidence
- Insider shares restricted until June 20, 2026
- Company completed IPO raising $9.2 million in December 2024
Negative
- Insiders have no immediate liquidity until June 20, 2026
- Extended lock-up may limit circulating float in near term
Details
News Market Reaction – HIT
On Dec 2, the day this news came out, HIT closed 19.02% below the previous close.
Data tracked by StockTitan Argus for the Dec 2 session.
Key Figures
- IPO gross proceeds
- $9.2 million
- Initial public offering in December 2024
- Original lock-up period
- 12 months
- Lock-up from final IPO prospectus dated December 20, 2024
- Lock-up extension
- 6 months
- Voluntary extension by executives, VPs, and Board
- Lock-up end date
- June 20, 2026
- Shares of current executive officers and Board restricted until this date
- IPO date
- December 20, 2024
- Date of final prospectus for initial public offering
Historical Context
-
Executives and directors extend IPO lock-up to June 20, 2026.
-
Non-binding LOI and Web Summit panel on HITChain blockchain platform.
-
Strong revenue and EBITDA growth with rising enrolled employees and partners.
-
Announcement of Davos 2026 panel featuring high-profile speaker on women leaders.
-
Scheduling and access details for Q3 2025 earnings call and webcast.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
lock-up restrictions financial
forward-looking statements regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.
Under this voluntary extension, all shares held by Health In Tech's current executive officers and Board of Directors will remain restricted from sale or transfer until June 20, 2026.
"Our leadership team remains highly committed to the long-term growth of Health In Tech," said Tim Johnson, CEO of Health In Tech. "By choosing to extend their lock-up period, our executives are demonstrating confidence in the Company's outlook and our ongoing initiatives in technology, underwriting automation, and market expansion."
Health In Tech completed its IPO in December 2024, raising gross proceeds of
Use of Forward‑Looking Statements
Certain statements in this press release are forward-looking statements for purposes of the safe harbor provisions under the
About Health In Tech
Health In Tech (Nasdaq: "HIT") is an Insurtech platform company backed by third-party AI technology, which offers a marketplace that aims to improve processes in the healthcare industry through vertical integration, process simplification, and automation. By removing friction and complexities, we streamline the underwriting, sales and service process for insurance companies, licensed brokers, and TPAs. Learn more at healthintech.com.
Investor Contact
Investor Relations:
ir@healthintech.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/health-in-tech-announces-voluntary-extension-of-lock-up-period-302629745.html
SOURCE Health In Tech
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.